目的:促进眼科糖皮质激素处方点评的同质化管理，提高点评效率。方法:在维普网、中国知网、万方数据、医脉通、用药助手、百度文库、PubMed、Cochrane Library、加拿大医学会临床实践指南文库、部分眼科学会官网检索眼科38个疾病的循证证据，运用指南研究与评价工具(Appraisal of guidelines Research and Evaluation Ⅱ，AGREE Ⅱ)进行评价，制订眼科糖皮质激素点评细则，并运用点评细则开展眼科糖皮质激素点评工作。结果:制订了 38个病种的点评细则，有或无糖皮质激素点评经验的2名药师运用点评细则点评2022年896张处方，耗时分别为2 h和2。5h，合理率分别为33。4％和33。8％。难以点评的处方占比下降24。1％。结论:制订点评细则可促进眼科糖皮质激素处方点评的开展。
Application of evidence-based evidence for formulating detailed rules for reviewing ophthalmic glucocorti-coid prescriptions
OBJECTIVE To promote the efficiency of prescription reviews through a homogeneous management of ophthal-mic glucocorticoids.METHODS Evidence-based information of 38 ophthalmological diseases was retrieved from the databases of VIP,China National Knowledge Infrastructure(CNKI),WANFANG DATA,Medlive,DXY,Baidu Library,PubMed,Cochrane Library,Canadian Medical Association:Clinical Practice Guideline and official websites of some ophthalmological soci-eties.Appraisal of Guidelines Research and Evaluation Ⅱ(AGREE Ⅱ)was utilized for evaluating these guidelines and literature items.Detailed rules were formulated for reviewing the prescriptions of ophthalmic glucocorticoids.RESULTS Two reviewers with or without glucocorticoid review experience applied the review rules for 896 prescriptions in 2022.It took 2 and 2.5 hours and reasonable rates were 33.4％and 33.8％.The percentage of prescriptions failing to complete reviews decreased by 24.1％.CONCLUSION Formulating detailed rules is conducive to promoting the development of reviewing ophthalmic glucocorticoid prescriptions.
NETL
NSTL
万方数据
